These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15172398)

  • 21. Neointimal progression and luminal narrowing in sirolimus-eluting stent treatment for bare metal in-stent restenosis: a quantitative intravascular ultrasound analysis.
    Sakurai R; Ako J; Hassan AH; Bonneau HN; Neumann FJ; Desmet W; Holmes DR; Yock PG; Fitzgerald PJ; Honda Y
    Am Heart J; 2007 Aug; 154(2):361-5. PubMed ID: 17643589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of sirolimus-eluting stent implantation for the treatment of ostial left anterior descending artery stenosis with intravascular ultrasound guidance.
    Seung KB; Kim YH; Park DW; Lee BK; Lee CW; Hong MK; Kim PJ; Chung WS; Tahk SJ; Park SW; Park SJ
    J Am Coll Cardiol; 2005 Sep; 46(5):787-92. PubMed ID: 16139126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detailed intravascular ultrasound analysis of Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial).
    Sakurai R; Hongo Y; Yamasaki M; Honda Y; Bonneau HN; Yock PG; Cutlip D; Popma JJ; Zimetbaum P; Fajadet J; Kuntz RE; Wijns W; Fitzgerald PJ;
    Am J Cardiol; 2007 Sep; 100(5):818-23. PubMed ID: 17719326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study.
    van der Hoeven BL; Liem SS; Jukema JW; Suraphakdee N; Putter H; Dijkstra J; Atsma DE; Bootsma M; Zeppenfeld K; Oemrawsingh PV; van der Wall EE; Schalij MJ
    J Am Coll Cardiol; 2008 Feb; 51(6):618-26. PubMed ID: 18261680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.
    Holmes DR; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA;
    JACC Cardiovasc Interv; 2008 Aug; 1(4):439-48. PubMed ID: 19463342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial.
    Kelbaek H; Helqvist S; Thuesen L; Kløvgaard L; Jørgensen E; Saunamäki K; Krusell LR; Bøtker HE; Engstrøm T; Jensen GV;
    Am Heart J; 2006 Nov; 152(5):882-6. PubMed ID: 17070149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sirolimus-eluting stent implantation in small coronary arteries: a three dimensional intravascular ultrasound study from the SIRIUS trial.
    Kaneda H; Ako J; Terashima M; Morino Y; Honda Y; Yock PG; Leon MB; Moses JW; Fitzgerald PJ;
    Int J Cardiol; 2010 Jan; 138(2):126-30. PubMed ID: 18804877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravascular ultrasound stent area of sirolimus-eluting stents and its impact on late outcome.
    Cheneau E; Pichard AD; Satler LF; Suddath WO; Weissman NJ; Waksman R
    Am J Cardiol; 2005 May; 95(10):1240-2. PubMed ID: 15878001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One-year results of the CRISTAL Trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents.
    Chevalier B; Moulichon R; Teiger E; Brunel P; Metzger JP; Pansieri M; Carrie D; Stoll HP; Wittebols K; Spaulding C; Fajadet J;
    J Interv Cardiol; 2012 Dec; 25(6):586-95. PubMed ID: 22994863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of overlapping bare-metal stents with sirolimus-eluting stents for long lesions in small coronary vessels.
    Kronsteiner E; Lee RW; Sweeney JP; Metallo JR; Stoehr JD; Fortuin FD
    J Invasive Cardiol; 2010 Feb; 22(2):76-9. PubMed ID: 20124593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sirolimus-eluting versus bare-metal stents for the reduction of coronary restenosis: 18-month angiographic results from the GERSHWIN Study.
    Brüggenjürgen B; McBride D; Bode C; Hamm CW; Kuck KH; Willich SN
    Herz; 2007 Dec; 32(8):650-5. PubMed ID: 18060612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).
    Schofer J; Schlüter M; Gershlick AH; Wijns W; Garcia E; Schampaert E; Breithardt G;
    Lancet; 2003 Oct; 362(9390):1093-9. PubMed ID: 14550694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation.
    Hong MK; Mintz GS; Lee CW; Park DW; Choi BR; Park KH; Kim YH; Cheong SS; Song JK; Kim JJ; Park SW; Park SJ
    Eur Heart J; 2006 Jun; 27(11):1305-10. PubMed ID: 16682378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
    Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
    Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of in-stent minimal lumen area at 9 months poststent implantation on 3-year target lesion revascularization-free survival: a serial intravascular ultrasound analysis from the TAXUS IV, V, and VI trials.
    Doi H; Maehara A; Mintz GS; Weissman NJ; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Stone GW
    Circ Cardiovasc Interv; 2008 Oct; 1(2):111-8. PubMed ID: 20031665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost effectiveness of the sirolimus-eluting stent in high-risk patients in Canada: an analysis from the C-SIRIUS trial.
    Rinfret S; Cohen DJ; Tahami Monfared AA; Lelorier J; Mireault J; Schampaert E
    Am J Cardiovasc Drugs; 2006; 6(3):159-68. PubMed ID: 16780389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis.
    Ako J; Morino Y; Honda Y; Hassan A; Sonoda S; Yock PG; Leon MB; Moses JW; Bonneau HN; Fitzgerald PJ
    J Am Coll Cardiol; 2005 Sep; 46(6):1002-5. PubMed ID: 16168282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial.
    Morice MC; Serruys PW; Barragan P; Bode C; Van Es GA; Stoll HP; Snead D; Mauri L; Cutlip DE; Sousa E
    J Am Coll Cardiol; 2007 Oct; 50(14):1299-304. PubMed ID: 17903626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravascular ultrasound comparison of sirolimus-eluting stent versus bare metal stent implantation in diseased saphenous vein grafts (from the RRISC [Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent] trial).
    Agostoni P; Vermeersch P; Semeraro O; Verheye S; Van Langenhove G; Van den Heuvel P; Convens C; Van den Branden F; Bruining N
    Am J Cardiol; 2007 Jul; 100(1):52-8. PubMed ID: 17599440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of late incomplete stent apposition: a comparison among bare-metal stents, intracoronary radiation and sirolimus-eluting stents.
    Miyazawa A; Tsujino I; Ako J; Shimada Y; Courtney BK; Sakurai R; Nakamura M; Okura H; Waseda K; Honda Y; Fitzgerald PJ
    J Invasive Cardiol; 2007 Dec; 19(12):515-8. PubMed ID: 18180522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.